Cefprozil: Difference between revisions
imported>David E. Volk (New page: {{subpages}} {{Chem infobox |align=right |image=center|thumb|250px|{{#ifexist:Template:Cefadroxil.jpg/credit|{{Cefadroxil.jpg/credit}}<br/>|}} |width=250px |molnam...) |
mNo edit summary |
||
Line 24: | Line 24: | ||
== References == | == References == | ||
<references/> | <references/> | ||
{{CZMed}} | {{CZMed}}[[Category:Suggestion Bot Tag]] |
Latest revision as of 06:00, 26 July 2024
| |||||||
cefprozil | |||||||
| |||||||
Uses: | antibiotic drug | ||||||
Properties: | beta-lactam | ||||||
Hazards: | see drug interactions | ||||||
|
Cefprozil, also called cefprozilo (INN-Spanish) and cefprozilum (INN-Latin), is a second-generation cephalosporin type of antibiotic medication used to treat bacterial infections. It is sold under the brand names Arzimol®, Brisoral®, Cronocef®, Procef® and Serozil®.
Chemistry
The IUPAC name for cefprozil is (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. It has a molecule formula C18H19N3O5S and an average molecule mass of 389.4260 gram/mole. Its antibacterial activity is due to the presence of a beta-lactam core structure, which binds with penicillin-binding proteins within bacteria, thus inhibiting bacterial cell wall synthesis.
References
The most up-to-date information about Cefprozil and other drugs can be found at the following sites.
- Cefprozil - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Cefprozil - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Cefprozil - Detailed information from DrugBank.